Stinging Nettle Leaf

Metadata

IMPORTANT: Leaf vs. Root Distinction

These are treated as DIFFERENT herbal drugs in European phytotherapy with different monographs, indications, and active compound profiles.

Approved Indications

German Commission E (Positive Monograph)

• Nettle leaf/herb: As supportive therapy for rheumatic conditions
• Also: irrigation therapy for inflammatory diseases of the lower urinary tract and prevention/treatment of kidney gravel

ESCOP

• Adjuvant in the symptomatic treatment of arthritis, arthroses, and/or rheumatic conditions
• Supportive therapy for increasing renal elimination of water (diuretic)

EMA/HMPC

• Traditional use for:
  • Relief of minor articular pain
  • As a diuretic to support flushing of the urinary tract (adjuvant in minor urinary complaints)

Agreement/Disagreement Among Authorities

• Agreement: All authorities recognize the adjuvant role in rheumatic/arthritic conditions; all emphasize the supportive/adjuvant nature (not standalone therapy)
• ESCOP is most specific about the arthritis indication
• Commission E also recognizes the diuretic/urinary indication for the leaf
• All emphasize that this is for adjuvant/supportive therapy, not primary treatment

Conditions Treated

Primary (Evidence-Supported)

• Osteoarthritis (adjuvant) — moderate evidence from small trials
• Rheumatoid arthritis (adjuvant) — traditional use + in vitro evidence
• General rheumatic complaints — traditional use with monograph support

Secondary (Traditional/Preliminary Evidence)

• Gout (traditional diuretic/anti-inflammatory use)
• Myalgia
• Lower urinary tract inflammation (diuretic irrigation therapy)

The Urtication Tradition

A distinctive and unique application is urtication — the deliberate application of fresh stinging nettle leaves to painful joints. This is an ancient European folk practice that has been validated by modern clinical trials:

• Fresh nettle stings deliver a complex mixture of histamine, acetylcholine, serotonin, formic acid, and leukotrienes directly into the skin
• This creates a counter-irritant effect and may have direct anti-inflammatory properties
• See clinical evidence section for RCT data

Mechanism of Action

Key Active Compounds (Leaf)

• Caffeic acid derivatives (chlorogenic acid, caffeic malic acid) — primary anti-inflammatory actives
• Flavonoids (quercetin, rutin, kaempferol glycosides)
• Minerals: Rich in calcium, potassium, silicon, iron
• Vitamins: A, C, K
• Carotenoids (beta-carotene, lutein)
• Organic acids (including caffeoylmalic acid)
• Stinging hairs (in fresh plant): Histamine, acetylcholine, serotonin, formic acid, leukotrienes

Pharmacological Mechanisms

1. NF-kB pathway inhibition: Standardized nettle extract (IDS 23) potently inhibits NF-kB activation, preventing nuclear translocation of the p65/p50 complex. This blocks transcription of pro-inflammatory genes [Source: Riehemann et al., 1999 — FEBS Letters]
2. TNF-alpha and IL-1beta suppression: IDS 23/1 extract achieves 50.5-79.5% inhibition of TNF-alpha and 90.0-99.2% inhibition of IL-1beta at highest tested concentrations [Source: Obertreis et al.]
3. COX-1 and COX-2 inhibition: Extracts inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis
4. Mast cell tryptase inhibition: Prevents mast cell degranulation, reducing histamine-mediated inflammation
5. 5-LOX modulation: Some evidence for lipoxygenase pathway effects
6. Diuretic effect: Supports elimination of uric acid and inflammatory metabolites (relevant to gout/rheumatic conditions)

Mechanism of Urtication (Fresh Nettle Sting)

The deliberate nettle sting delivers:

• Counter-irritation (gate theory of pain modulation)
• Local histamine and serotonin release — may trigger anti-inflammatory feedback mechanisms
• Direct delivery of anti-inflammatory compounds to periarticular tissue
• May modulate local immune responses [UNCERTAIN — mechanism not fully elucidated]

Clinical Evidence Summary

Clinical Trials for Arthritis

Observational/Open Studies

• Beer & Wegener (2008): Observational study of 8,955 patients using nettle leaf extract showed favorable safety and tolerability profile
• Multiple open studies in Germany and Eastern Europe support traditional use as adjuvant in rheumatic conditions

The NSAID-Sparing Effect

The Chrubasik 1997 study is clinically significant: combining nettle leaf with a reduced dose of diclofenac (50 mg instead of 200 mg) achieved equivalent pain relief. This suggests nettle leaf’s primary clinical role may be as an NSAID-sparing adjuvant, allowing patients to reduce NSAID doses and thereby reduce NSAID side effects.

Limitations of Evidence

• Small sample sizes: The largest arthritis-specific RCT (Randall 2000) had only 27 patients
• Few placebo-controlled RCTs specifically for OA/RA with oral nettle leaf extract
• The NSAID-sparing study was open-label, not blinded
• Urtication studies are inherently difficult to blind (patients know when they are being stung)
• Evidence is strongest for the anti-inflammatory mechanism (in vitro) but clinical trial evidence for arthritis specifically is limited [NEEDS-RESEARCH]

European vs. US/Anglophone Consensus

Safety Profile

Contraindications

• Pregnancy: Avoid (traditional use as abortifacient in some cultures; uterine stimulant effects reported)
• Lactation: Insufficient data; avoid as precaution
• Children: Insufficient data for arthritis indication
• Edema due to cardiac or renal insufficiency: The diuretic effect may complicate fluid management; do not use irrigation therapy in these conditions

Drug Interactions

• Anticoagulants (warfarin): Nettle leaf is high in vitamin K; may reduce anticoagulant effectiveness. Monitor INR
• Antihypertensives: Potential additive hypotensive effect
• Diuretics: Additive diuretic effect; monitor electrolytes
• Lithium: Diuretic effect may reduce lithium clearance; potential for lithium toxicity
• Diabetic medications: May potentiate hypoglycemic effects
• Sedatives/CNS depressants: Possible additive sedative effect (theoretical)
• NSAIDs: May allow NSAID dose reduction (beneficial interaction; see Chrubasik 1997)

Side Effects

• Generally very well-tolerated
• Mild GI complaints (occasional)
• Allergic skin reactions (rare)
• Urtication-specific: Local stinging, erythema, urticaria at application site (expected and self-limiting; resolves within hours)
• No significant hepatic, renal, or hematological toxicity

Pregnancy and Lactation

• Pregnancy: AVOID. Traditional use as uterine stimulant/abortifacient in some cultures; insufficient modern safety data
• Lactation: Insufficient data; traditionally believed to promote milk production (galactagogue), but safety not confirmed. Avoid until more data available

Clinical Dosage

Recommended Forms and Doses

Key Dosing Principles

1. Adjuvant role: Best used in combination with other treatments (NSAIDs, other herbs, physical therapy), not as sole therapy for significant arthritis
2. NSAID-sparing strategy: Consider combining with reduced-dose NSAID (see Chrubasik 1997)
3. Adequate fluid intake: If used for diuretic/irrigation therapy, ensure adequate hydration (>=2 L/day)
4. Duration: Safe for extended use (up to 6 months studied); no specific duration limits
5. Vitamin K content: Relevant for patients on warfarin; keep intake consistent
6. Urtication: For those willing to try it, fresh nettle applied to painful joints 1x/day for 1-2 weeks is a validated approach (Randall 2000)

Key European Products

• IDS 23 (standardized extract) — used in pharmacological research
• Various German pharmacy preparations (Brennnesselblaetter-Tee, etc.)
• Hox Alpha (Germany) — combination product
• Widely available as bulk dried herb for tea preparation

Sources

• Riehemann K et al. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-kappaB. FEBS Lett. 1999;442(1):89-94.
• Randall C et al. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med. 2000;93(6):305-309.
• Chrubasik S et al. Evidence for antirheumatic effectiveness of Herba Urticae dioicae in acute arthritis: a pilot study. Phytomedicine. 1997;4(2):105-108.
• Mittman P. Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis. Planta Med. 1990;56(1):44-47.
• Obertreis B et al. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum urticae dioicae foliorum. Arzneimittelforschung. 1996;46(2):159-167.
• ESCOP. Urticae folium/herba (Nettle leaf/herb) Monograph.
• EMA/HMPC. Assessment report on Urtica dioica L., Urtica urens L., folium.
• German Commission E. Urtica dioica folium Monograph.

Connections

• DISTINCT from nettle ROOT (Urtica dioica radix) used for BPH — different monograph, different actives
• Compare with Devils Claw and Willow Bark — nettle leaf as adjuvant to these primary therapies
• Compare with Boswellia — both oral anti-inflammatories; both primarily adjuvant